867 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Carcinoma, Bronchogenic" (867 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
5 Not yet recruiting A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
Condition: Lung Cancer in Normal and Malignant Tumors
Intervention: Drug: ALA-induced Fluorescence
6 Not yet recruiting Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas
Conditions: Small Cell Lung Cancer (SCLC);   Neuroendocrine (NE) Tumors;   Large Cell Neuroendocrine (NE) Tumors
Intervention: Drug: Rhenium Re 188-P2045
7 Recruiting Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy
Condition: Carcinoma, Non-small-cell Lung
Interventions: Drug: maintenance pemetrexed;   Drug: pemetrexed at progression
8 Recruiting Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation
Conditions: Non-small-cell Lung Cancer;   Radiation Pneumonitis
Intervention: Other: SPECT-based treatment plan
9 Available Afatinib Expanded Access Program
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: afatinib
10 Unknown  Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Tarceva (erlotinib)
11 Unknown  Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC
Conditions: Carcinoma, Non-Small-Cell Lung;   Neoplasm Metastasis
Intervention: Drug: Erlotinib, Temozolomide
12 Recruiting Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis
Condition: EGFR Mutation Positive Non-small Cell Lung Cancer
Intervention: Drug: EGFR TKIs (gefitinib, erlotinib, afatinib, et al)
13 Recruiting Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Conditions: Malignant Pericardial Effusion;   Malignant Pleural Effusion;   Recurrent Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Other: cytology specimen collection procedure;   Procedure: therapeutic procedure;   Drug: targeted therapy;   Other: laboratory biomarker analysis
14 Recruiting Photodynamic Therapy During Surgery in Treating Patients With Non-Small Cell Lung Cancer That Can be Removed by Surgery
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: temoporfin;   Procedure: therapeutic conventional surgery;   Drug: photodynamic therapy;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Unknown  Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases
Condition: Non-small Cell Lung Cancer
Intervention: Radiation: neoadjuvant chemoradiotherapy
16 Recruiting Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease
Condition: NSCLC
Interventions: Drug: Icotinib of routine dose;   Drug: Icotinib of high dose
17 Recruiting First Line Gefitinib by FDG-PET Metabolic Response
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Gefitinib
18 Recruiting Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Oshadi D and Oshadi R;   Drug: Docetaxel
19 Recruiting Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Subjects Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer Who Are Current or Former Smokers
Condition: Non-squamous Non-small Cell Lung Cancer
Interventions: Drug: Veliparib;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Pemetrexed
20 Unknown  Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
Condition: Malignant Pleural Effusion
Interventions: Drug: Bevacizumab;   Drug: Cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years